Cheryl Pegus
CIK: 0001572448
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- May 20, 2026BSX
BOSTON SCIENTIFIC CORP
Purchase(P)Direct1.8K shares at avg. $56.49$100K - May 7, 2026BSX
BOSTON SCIENTIFIC CORP
Award(A)DirectDeferred Stock Units
1.3K shares- - May 7, 2026BSX
BOSTON SCIENTIFIC CORP
Award(A)DirectDeferred Stock Units
3.8K shares- - Mar 2, 2026BSX
BOSTON SCIENTIFIC CORP
Award(A)DirectDeferred Stock Units
24 shares- - Nov 4, 2025CON
Concentra Group Holdings Parent, Inc.
Award(A)Direct7.7K shares- - May 8, 2025BSX
BOSTON SCIENTIFIC CORP
Award(A)DirectDeferred Stock Units
605 shares- - May 8, 2025BSX
BOSTON SCIENTIFIC CORP
Award(A)DirectDeferred Stock Units
2.1K shares- - Nov 26, 2024CON
Concentra Group Holdings Parent, Inc.
Award(A)Direct6.5K shares- - Nov 26, 2024CON
Concentra Group Holdings Parent, Inc.
Award(A)Direct6.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 |  BSX BOSTON SCIENTIFIC CORP | Purchase(P) | 1,770 | $56.49 | $99,987 | Direct |
| May 7, 2026 | BSX BOSTON SCIENTIFIC CORP | Award(A) Deferred Stock Units | 1,281 | - | - | Direct |
| May 7, 2026 | BSX BOSTON SCIENTIFIC CORP | Award(A) Deferred Stock Units | 3,800 | - | - | Direct |
| Mar 2, 2026 | BSX BOSTON SCIENTIFIC CORP | Award(A) Deferred Stock Units | 24 | - | - | Direct |
| Nov 4, 2025 |  CON Concentra Group Holdings Parent, Inc. | Award(A) | 7,748 | - | - | Direct |
| May 8, 2025 | BSX BOSTON SCIENTIFIC CORP | Award(A) Deferred Stock Units | 605 | - | - | Direct |
| May 8, 2025 | BSX BOSTON SCIENTIFIC CORP | Award(A) Deferred Stock Units | 2,081 | - | - | Direct |
| Nov 26, 2024 | CON Concentra Group Holdings Parent, Inc. | Award(A) | 6,496 | - | $0 | Direct |
| Nov 26, 2024 | CON Concentra Group Holdings Parent, Inc. | Award(A) | 6,496 | - | $0 | Direct |
1-9 of 9 transactions
About Pegus Cheryl
Pegus Cheryl (SEC CIK 0001572448) files insider reports with the SEC as Director of BOSTON SCIENTIFIC CORP (BSX) and Director of Concentra Group Holdings Parent, Inc. (CON).
Signal8 holds 6 ownership filings by Pegus Cheryl, all Form 4s, filed between Nov 29, 2024 and May 21, 2026. Those filings report 9 transactions, from Nov 26, 2024 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Pegus Cheryl's filings is in MARLBOROUGH, MA.
Recent filings by Pegus Cheryl
- May 20, 2026: Open-market purchase of BSX shares (Form 4, code P).
- May 7, 2026: Grants or awards of BSX derivative securities (2 lines, Form 4, code A).
- Mar 2, 2026: Grant or award of BSX derivative securities (Form 4, code A).
- Nov 4, 2025: Grant or award of CON shares (Form 4, code A).
- May 8, 2025: Grants or awards of BSX derivative securities (2 lines, Form 4, code A).
Other insiders filing for BOSTON SCIENTIFIC CORP (BSX)
- O'Connor Padraig Andrew, EVP, Global Operations
- Morano Susan E, Director
- Woodworth Emily, SVP, Global Controller and CAO
- Monson Jonathan, EVP and CFO
- Habiger David C, Director
- Mahoney Michael F, Chairman, President & CEO